Cortigent Inc (CRGT): Fair Value Consensus

This price trend chart for Cortigent, Inc. (CRGT) illustrates the asset's dynamics, with its value currently at . The business relies on the exclusive Orion and Argus systems, which enable vision restoration through cortical stimulation. Stability is ensured by in-house brain-computer interface experts and regulatory specialists. Technological development is driven by close collaboration with leading neurobiologists and specialized medical centers.

This indicator aggregates average expert price targets, measuring the asset's fundamental value potential relative to current market quotes. For Cortigent, Inc. (CRGT), whose capitalization depends on the success of neurotechnology developments in the absence of operating cash flow, changes in the consensus share price forecast reflect the market's level of confidence in clinical results, turning chart volatility into an indicator of investment risk.